Tanvex BioPharma (6541.TW) Earnings Analysis
Tanvex BioPharma (6541.TW) next reports earnings on 2026-08-06, consensus EPS -1.66 TWD. Last quarter (2026-03-04) it missed with EPS -1.6 TWD vs -0.755 TWD est (-111.9%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -7.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6541.TW next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.66 TWD |
| Revenue estimate | 0.12B |
6541.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-04 | -1.6 TWD | -0.755 TWD | -111.9% | Miss |
| 2025-08-14 | -1.42813 TWD | n/a | n/a | n/a |
| 2025-03-12 | -1.69566 TWD | n/a | n/a | n/a |
| 2024-11-08 | -1.94 TWD | n/a | n/a | n/a |
| 2024-08-09 | -2.31087 TWD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
6541.TW valuation and analyst view
| Trailing P/E | -7.16 |
|---|---|
| Trailing EPS | -5.38176 TWD |
| Price / book | 1.97 |
| Dividend yield | 0.00% |
| Market cap | 10.60B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Tanvex BioPharma (6541.TW)'s next earnings date?
Tanvex BioPharma is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.66 TWD and revenue estimate of 0.12B.
Did 6541.TW beat earnings last quarter?
In its 2026-03-04 report, 6541.TW posted EPS of -1.6 TWD versus a -0.755 TWD estimate — a miss of 111.9%.
What is 6541.TW's earnings track record?
Over the last 1 reported quarters with consensus data, 6541.TW beat estimates 0 times (0%).
What is 6541.TW's current P/E ratio and EPS?
6541.TW trades at a trailing P/E of -7.16 on trailing EPS of -5.381758225966865 TWD.
What do analysts rate 6541.TW?
6541.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.